Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MLNT
DateTimeSourceHeadlineSymbolCompany
24/06/202021:02GlobeNewswire Inc.Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of TetraphaseNASDAQ:MLNTMelinta Therapeutics Inc
09/06/202021:02GlobeNewswire Inc.Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase PharmaceuticalsNASDAQ:MLNTMelinta Therapeutics Inc
04/03/202021:03GlobeNewswire Inc.Melinta Therapeutics Confirms Deerfield as Successful Bidder for CompanyNASDAQ:MLNTMelinta Therapeutics Inc
13/02/202021:02GlobeNewswire Inc.Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:MLNTMelinta Therapeutics Inc
05/02/202016:15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MLNTMelinta Therapeutics Inc
08/01/202021:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
27/12/201914:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
27/12/201914:02GlobeNewswire Inc.Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit FacilityNASDAQ:MLNTMelinta Therapeutics Inc
12/11/201922:07GlobeNewswire Inc.Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019NASDAQ:MLNTMelinta Therapeutics Inc
12/11/201922:00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
06/11/201922:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
25/10/201917:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
25/10/201917:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
24/10/201921:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
24/10/201921:02GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...NASDAQ:MLNTMelinta Therapeutics Inc
01/10/201915:07PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019NASDAQ:MLNTMelinta Therapeutics Inc
13/09/201920:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
03/09/201921:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
03/09/201921:05GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and DirectorNASDAQ:MLNTMelinta Therapeutics Inc
13/08/201911:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201912:41Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201912:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201912:31GlobeNewswire Inc.Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession PlanNASDAQ:MLNTMelinta Therapeutics Inc
09/08/201912:30GlobeNewswire Inc.Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:MLNTMelinta Therapeutics Inc
06/08/201922:04GlobeNewswire Inc.Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results ReportingNASDAQ:MLNTMelinta Therapeutics Inc
16/07/201921:51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
16/07/201912:30GlobeNewswire Inc.Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
10/07/201920:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNTMelinta Therapeutics Inc
02/07/201922:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
01/07/201922:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLNT